The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-cola Euro. Regulatory News (CCEP)

Share Price Information for Coca-cola Euro. (CCEP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.994%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 68.20
CCEP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

27 May 2021 12:00

RNS Number : 0586A
Coca-Cola Europacific Partners plc
27 May 2021
 

Coca-Cola Europacific Partners plc - Results of 2021 Annual General Meeting

 

The Annual General Meeting of Coca-Cola Europacific Partners plc (the "Company") was held at Pemberton House, Bakers Road, Uxbridge UB8 1EZ on 26 May 2021.

 

All 28 resolutions put to the members were passed on a poll. Accordingly, resolutions 1 to 23 were passed as ordinary resolutions and resolutions 24 to 28 were passed as special resolutions.

 

The results of the polls are set out below:

 

Resolution

For (see note 1)

Against (see note 1)

Issued share capital represented by votes (see note 2) %

Votes withheld (see note 3)

Votes

%

Votes

%

1

Receipt of the Report and Accounts

395,303,737

99.99%

36,920

0.01%

86.74%

155,065

2

Approval of the Directors' Remuneration Report

334,980,592

84.96%

59,318,003

15.04%

86.51%

1,197,127

3

Election of Manolo Arroyo as a director of the Company

392,470,375

99.27%

2,879,562

0.73%

86.74%

145,785

4

Election of John Bryant as a director of the Company

393,338,033

99.49%

2,016,897

0.51%

86.74%

140,792

5

Election of Christine Cross as a director of the Company

383,147,691

96.91%

12,210,325

3.09%

86.74%

137,706

6

Election of Brian Smith as a director of the Company

390,515,168

98.78%

4,834,589

1.22%

86.74%

145,965

7

Election of Garry Watts as a director of the Company

382,904,931

96.86%

12,409,137

3.14%

86.73%

181,654

8

Re-election of Jan Bennink as a director of the Company

394,361,750

99.75%

998,875

0.25%

86.74%

135,097

9

Re-election of José Ignacio Comenge as a director of the Company

392,512,620

99.28%

2,840,567

0.72%

86.74%

142,535

10

Re-election of Damian Gammell as a director of the Company

393,259,737

99.47%

2,104,150

0.53%

86.74%

131,835

11

Re-election of Nathalie Gaveau as a director of the Company

379,321,297

95.94%

16,038,375

4.06%

86.74%

136,050

12

Re-election of Álvaro Gómez-Trénor Aguilar as a director of the Company

392,499,065

99.28%

2,852,221

0.72%

86.74%

144,436

13

Re-election of Thomas Johnson as a director of the Company

383,044,549

96.90%

12,273,009

3.10%

86.73%

178,164

14

Re-election of Dagmar Kollmann as a director of the Company

356,359,214

90.14%

39,000,698

9.86%

86.74%

135,810

15

Re-election of Alfonso Líbano Daurella as a director of the Company

392,666,094

99.32%

2,684,875

0.68%

86.74%

144,753

16

Re-election of Mark Price as a director of the Company

393,787,394

99.60%

1,574,364

0.40%

86.74%

133,964

17

Re-election of Mario Rotllant Solá as a director of the Company

346,243,609

87.73%

48,404,586

12.27%

86.59%

847,527

18

Re-election of Dessi Temperley as a director of the Company

393,359,145

99.49%

2,000,194

0.51%

86.74%

136,383

19

Reappointment of the Auditor

391,342,810

98.98%

4,014,195

1.02%

86.74%

138,717

20

Remuneration of the Auditor

394,127,953

99.69%

1,230,465

0.31%

86.74%

137,304

21

Political Donations

394,359,240

99.81%

739,806

0.19%

86.68%

396,676

22

Authority to allot new shares

385,638,835

97.55%

9,701,007

2.45%

86.74%

155,880

23

Waiver of mandatory offer provisions set out in Rule 9 of the Takeover Code (see note 4)

182,828,208

82.11%

39,824,695

17.89%

48.85%

171,043,169

24

Authority to disapply pre-emption rights

394,048,227

99.91%

340,603

0.09%

86.53%

1,106,892

25

Authority to disapply pre-emption rights in connection with an acquisition or specified capital investment

392,985,433

99.63%

1,464,605

0.37%

86.54%

1,045,684

26

Authority to purchase own shares on market

393,514,124

99.79%

823,661

0.21%

86.52%

1,157,937

27

Authority to purchase own shares off market

393,442,059

99.78%

882,766

0.22%

86.51%

1,170,897

28

Notice period for general meetings other than AGM

387,702,676

98.14%

7,338,658

1.86%

86.67%

454,388

 

Notes:

 

1

Votes "For" and "Against" are expressed as a percentage of votes received.

 

2

As at 5.15pm on Monday 24 May 2021, the time by which shareholders who wanted to attend, speak and vote at the AGM must have been entered on the Company's register of members, there were 455,791,226 ordinary shares in issue.

 

3

A "Vote Withheld" is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

 

4

Resolution 23 was put to the AGM as a resolution of the shareholders of the Company other than Olive Partners, S.A. ("Olive") or any concert party of Olive.

 

In particular, in accordance with Section 6(A) of Appendix 1 to the Takeover Code, the Company announces that shareholders approved resolution 23, setting out the terms of the waiver of mandatory offer provisions in Rule 9 of the Takeover Code (the "Waiver").

 

Olive is currently interested in 166,128,987 shares in the Company and the Waiver does not entitle Olive to be interested in a greater number of shares. The Waiver would allow Olive's interest in shares as a percentage of the Company's total shares to increase as a result of the exercise of the Company's authorities to purchase its own shares, but only to the extent that the resulting interest of Olive, together with any concert parties, in the shares of the Company did not then exceed 40.5433%.

 

In accordance with Listing Rule 14.3.6R, copies of the resolutions that do not constitute ordinary business at an annual general meeting will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

CONTACTS

 

Company Secretariat

Clare Wardle

T +44 (0)20 7355 8406

Investor Relations

Sarah Willett

T +44 (0)7970 145 218

Media Relations

Shanna Wendt

T +44 (0)7976 595 168

 

 

 

ABOUT CCEP

 

Coca-Cola Europacific Partners is one of the leading consumer goods companies in the world. We make, move and sell some the world's most loved brands - serving 600 million consumers and helping 1.75 million customers across 29 countries grow.

 

We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support. 

 

The Company is listed on Euronext Amsterdam, the New York Stock Exchange, London Stock Exchange and on the Spanish Stock Exchanges, trading under the symbol CCEP.

 

For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on Twitter at @CocaColaEP

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSEWFSWEFSEEI
Date   Source Headline
25th Jul 20234:00 pmRNSDirector/PDMR Shareholding
21st Jul 20232:30 pmRNSDirector/PDMR Shareholding
13th Jul 20233:30 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20233:00 pmRNSDirector/PDMR Shareholding
8th Jun 202310:50 amRNSDirector/PDMR Shareholding
1st Jun 20232:15 pmRNSTotal Voting Rights
26th May 20234:30 pmRNSDirector/PDMR Shareholding
25th May 202311:30 amRNSResult of AGM
23rd May 20233:00 pmRNSDirector/PDMR Shareholding
18th May 202311:30 amRNSDirector/PDMR Shareholding
15th May 20233:30 pmRNSLetter to Shareholders
4th May 20234:00 pmRNSDirector/PDMR Shareholding
2nd May 20232:45 pmRNSTotal Voting Rights
25th Apr 20237:00 amRNSQ1 Trading Update & Interim Dividend Declaration
21st Apr 20234:58 pmRNSDirector/PDMR Shareholding
14th Apr 20231:30 pmRNSDirector/PDMR Shareholding
12th Apr 20239:00 amRNSNotice of AGM
3rd Apr 20232:45 pmRNSTotal Voting Rights
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
22nd Mar 202311:45 amRNSDirector/PDMR Shareholding
17th Mar 20233:30 pmRNSBlock listing Interim Review
17th Mar 202311:55 amRNSAnnual Financial Report
14th Mar 20239:45 amRNSDirector/PDMR Shareholding
13th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20233:50 pmRNSDirector/PDMR Shareholding
1st Mar 20233:20 pmRNSTotal Voting Rights
23rd Feb 202310:30 amRNSDirector/PDMR Shareholding
16th Feb 20237:00 amRNSPreliminary Unaudited Results Q4 & FY 2022
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 202310:00 amRNSDirectorate Change
1st Feb 20233:30 pmRNSTotal Voting Rights
23rd Jan 20234:30 pmRNSDirector/PDMR Shareholding
16th Jan 20232:30 pmRNSDirector/PDMR Shareholding
3rd Jan 20232:40 pmRNSTotal Voting Rights
21st Dec 20223:45 pmRNSDirector/PDMR Shareholding
1st Dec 20223:15 pmRNSTotal Voting Rights
23rd Nov 20228:00 amRNSDirector/PDMR Shareholding
15th Nov 20225:30 pmRNSDirector/PDMR Shareholding
4th Nov 20225:20 pmRNSDirector/PDMR Shareholding
2nd Nov 20227:00 amRNSQ3, Investor Event & Interim Dividend Declaration
1st Nov 20223:45 pmRNSTotal Voting Rights
21st Oct 20223:00 pmRNSDirector/PDMR Shareholding
14th Oct 20222:30 pmRNSDirector/PDMR Shareholding
3rd Oct 20222:30 pmRNSTotal Voting Rights
22nd Sep 20223:00 pmRNSDirector/PDMR Shareholding
20th Sep 202210:00 amRNSBlock listing Interim Review
16th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20224:36 pmRNSPrice Monitoring Extension
9th Sep 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.